UB Paderborn / Katalog / Suche / in CDI

636 QUANTITATIVE EVALUATION OF INK4A PROMOTER METHYLATION USING PYROSEQUENCING AND CIRCULATING CELL-FREE DNA FROM PATIENTS WITH HEPATOCELLULAR CARCINOMA

Journal of hepatology, 2013-04, Vol.58, p.S259-S259

2013

Link zum Volltext

Verfügbarkeit prüfen

Randomised trial: survival benefit and safety of adjuvant dose-dense chemotherapy for node-positive breast cancer

British journal of cancer, 2006-05, Vol.94 (9), p.1237-1244

2006

Link zum Volltext

Verfügbarkeit prüfen

Non-pegylated liposomal doxorubicin and docetaxel in metastatic breast cancer: final results of a phase II trial

Cancer chemotherapy and pharmacology, 2009-07, Vol.64 (2), p.401-406

2009

Link zum Volltext

Verfügbarkeit prüfen

Primary chemotherapy with gemcitabine as prolonged infusion, non-pegylated liposomal doxorubicin and docetaxel in patients with early breast cancer: final results of a phase II trial

Annals of oncology, 2005-10, Vol.16 (10), p.1624-1631

2005

Link zum Volltext

Verfügbarkeit prüfen

Comparative Study of Surgical Margins and Cosmetic Outcome in Lumpectomy versus Segmental Resection in Breast Cancer

European surgical research, 2011-01, Vol.47 (4), p.231-239

2011

Link zum Volltext

Verfügbarkeit prüfen

Abstract P1-13-01: Final results of the ASG1-3 study, a randomized phase III study comparing a standard dose chemotherapy with epirubicin/cyclophosphamide and paclitaxel with a dose dense regimen with epirubicin and paclitaxel

Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4_Supplement), p.P1-P1-13-01

2019

Link zum Volltext

Verfügbarkeit prüfen

Familiärer Brustkrebs: 2-Stufen-Gendiagnostik zum Nachweis von BRCA1- und BRCA2-Mutationen in Risikofamilien

Geburtshilfe und Frauenheilkunde, 2000-06, Vol.60 (6), p.326-332

2000

Link zum Volltext

Verfügbarkeit prüfen

Abstract P1-14-05: Phase I/II Trial of primary chemotherapy with non-pegylated liposomal doxorubicin, paclitaxel and lapatinib in patients with HER2-positive, early stage breast cancer

Cancer research (Chicago, Ill.), 2012-12, Vol.72 (24_Supplement), p.P1-P1-14-05

2012

Link zum Volltext

Verfügbarkeit prüfen

Primary chemotherapy with doxorubicin and paclitaxel in patients with early breast cancer: final results of a multicenter phase II study

Journal of cancer research and clinical oncology, 2004-11, Vol.130 (11), p.657-663

2004

Link zum Volltext

Verfügbarkeit prüfen

Intraductal component in invasive breast cancer: analysis of 250 resected surgical specimens

Breast (Edinburgh), 2001-10, Vol.10 (5), p.405-410

2001

Link zum Volltext

Verfügbarkeit prüfen

Adjuvant treatment of breast cancer patients with 1–3 positive lymph nodes: vinorelbine plus epirubicin; vinorelbine plus epirubicin sequential followed up by paclitaxel; epirubicin plus cyclophosphamide; epirubicin plus cyclophosphamide sequential followed up by paclitaxel. A phase II study

Breast (Edinburgh), 2003-06, Vol.12 (3), p.208-211

2003

Link zum Volltext

Verfügbarkeit prüfen

Dose-dense adjuvant chemotherapy for node-positive breast cancer in women 60 years and older: Feasibility and tolerability in a subset of patients in a randomized trial

Critical reviews in oncology/hematology, 2006-05, Vol.58 (2), p.166-175

2006

Link zum Volltext

Verfügbarkeit prüfen

Primary chemotherapy with gemcitabine, liposomal doxorubicin and docetaxel in patients with locally advanced breast cancer: results of a phase I trial

Anti-cancer drugs, 2005-01, Vol.16 (1), p.21-29

2005

Link zum Volltext

Verfügbarkeit prüfen

Effect of adjuvant chemotherapy on circulating levels of ICAM, VCAM, VEGF and VEGFD in women with lymph node positive breast cancer.(NOGGO trial)

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.9602-9602

2004

Link zum Volltext

Verfügbarkeit prüfen

Effect of adjuvant chemotherapy on circulating levels of ICAM, VCAM, VEGF and VEGFD in women with lymph node positive breast cancer.(NOGGO trial)

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.9602-9602

2004

Link zum Volltext

Verfügbarkeit prüfen

A phase III randomised trial comparing the tolerability of dose-dense chemotherapy in older to that in younger breast cancer patients with four or more positive lymph nodes

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.589-589

2004

Link zum Volltext

Verfügbarkeit prüfen

A phase III randomised trial comparing the tolerability of dose-dense chemotherapy in older to that in younger breast cancer patients with four or more positive lymph nodes

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.589-589

2004

Link zum Volltext

Verfügbarkeit prüfen

Detection of BRCA1 and BRCA2 mutations in breast cancer families by a comprehensive two‐stage screening procedure

International journal of cancer, 2000-02, Vol.85 (4), p.474-481

2000

Link zum Volltext

Verfügbarkeit prüfen

Dose-intensive adjuvant chemotherapy with epirubicin/paclitaxel vs. epirubicin/cyclophosphamide in breast cancer patients with 4–9/over 9 (second group) positive nodes: preliminary data of this phase II/III trial

European journal of cancer (1990), 1999-09, Vol.35, p.S204-S204

1999

Link zum Volltext

Verfügbarkeit prüfen

New approach to tumor marking. Clip implantation prior to primary chemotherapy on patients with mammary carcinoma

European journal of cancer (1990), 1999-09, Vol.35, p.S319-S319

1999

Link zum Volltext

Verfügbarkeit prüfen

Familiärer Brustkrebs: 2-Stufen-Gendiagnostik zum Nachweis von BRCA1- und BRCA2-Mutationen in Risikofamilien - A Two-stage Test to Identify BRCA-1 and BRCA-2 Mutations in High-risk Families

Geburtshilfe und Frauenheilkunde, 2000, Vol.60 (6), p.326-332

2000

Link zum Volltext

Verfügbarkeit prüfen

Kasuistischer Beitrag zur Lokalisation des Non-Hodgkin-Lymphoms in der weiblichen Brust

Geburtshilfe und Frauenheilkunde, 1999-10, Vol.59 (10), p.523-527

1999

Link zum Volltext

Verfügbarkeit prüfen

Dose intensified adjuvant chemotherapy in high risk breast carcinoma with 4-9 positive lymph nodes

Zentralblatt für Gynäkologie, 2000, Vol.122 (4), p.207

2000

Link zum Volltext

Verfügbarkeit prüfen

Hepar lobatum carcinomatosum due to chemotherapy of a metastatic breast carcinoma

General & diagnostic pathology, 1996-03, Vol.141 (3-4), p.279

1996

Link zum Volltext

Verfügbarkeit prüfen

Case report of squamous epithelial cancer of the female breast

Zentralblatt für Gynäkologie, 1993, Vol.115 (11), p.500

1993

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

636 QUANTITATIVE EVALUATION OF INK4A PROMOTER METHYLATION USING PYROSEQUENCING AND CIRCULATING CELL-FREE DNA FROM PATIENTS WITH HEPATOCELLULAR CARCINOMA

Randomised trial: survival benefit and safety of adjuvant dose-dense chemotherapy for node-positive breast cancer

Non-pegylated liposomal doxorubicin and docetaxel in metastatic breast cancer: final results of a phase II trial

Primary chemotherapy with gemcitabine as prolonged infusion, non-pegylated liposomal doxorubicin and docetaxel in patients with early breast cancer: final results of a phase II trial

Comparative Study of Surgical Margins and Cosmetic Outcome in Lumpectomy versus Segmental Resection in Breast Cancer

Abstract P1-13-01: Final results of the ASG1-3 study, a randomized phase III study comparing a standard dose chemotherapy with epirubicin/cyclophosphamide and paclitaxel with a dose dense regimen with epirubicin and paclitaxel

Familiärer Brustkrebs: 2-Stufen-Gendiagnostik zum Nachweis von BRCA1- und BRCA2-Mutationen in Risikofamilien

Abstract P1-14-05: Phase I/II Trial of primary chemotherapy with non-pegylated liposomal doxorubicin, paclitaxel and lapatinib in patients with HER2-positive, early stage breast cancer

Primary chemotherapy with doxorubicin and paclitaxel in patients with early breast cancer: final results of a multicenter phase II study

Intraductal component in invasive breast cancer: analysis of 250 resected surgical specimens

Adjuvant treatment of breast cancer patients with 1–3 positive lymph nodes: vinorelbine plus epirubicin; vinorelbine plus epirubicin sequential followed up by paclitaxel; epirubicin plus cyclophosphamide; epirubicin plus cyclophosphamide sequential followed up by paclitaxel. A phase II study

Dose-dense adjuvant chemotherapy for node-positive breast cancer in women 60 years and older: Feasibility and tolerability in a subset of patients in a randomized trial

Primary chemotherapy with gemcitabine, liposomal doxorubicin and docetaxel in patients with locally advanced breast cancer: results of a phase I trial

Effect of adjuvant chemotherapy on circulating levels of ICAM, VCAM, VEGF and VEGFD in women with lymph node positive breast cancer.(NOGGO trial)

Effect of adjuvant chemotherapy on circulating levels of ICAM, VCAM, VEGF and VEGFD in women with lymph node positive breast cancer.(NOGGO trial)

A phase III randomised trial comparing the tolerability of dose-dense chemotherapy in older to that in younger breast cancer patients with four or more positive lymph nodes

A phase III randomised trial comparing the tolerability of dose-dense chemotherapy in older to that in younger breast cancer patients with four or more positive lymph nodes

Detection of BRCA1 and BRCA2 mutations in breast cancer families by a comprehensive two‐stage screening procedure

Dose-intensive adjuvant chemotherapy with epirubicin/paclitaxel vs. epirubicin/cyclophosphamide in breast cancer patients with 4–9/over 9 (second group) positive nodes: preliminary data of this phase II/III trial

New approach to tumor marking. Clip implantation prior to primary chemotherapy on patients with mammary carcinoma

Familiärer Brustkrebs: 2-Stufen-Gendiagnostik zum Nachweis von BRCA1- und BRCA2-Mutationen in Risikofamilien - A Two-stage Test to Identify BRCA-1 and BRCA-2 Mutations in High-risk Families

Kasuistischer Beitrag zur Lokalisation des Non-Hodgkin-Lymphoms in der weiblichen Brust

Dose intensified adjuvant chemotherapy in high risk breast carcinoma with 4-9 positive lymph nodes

Hepar lobatum carcinomatosum due to chemotherapy of a metastatic breast carcinoma

Case report of squamous epithelial cancer of the female breast

Suchergebnisse filtern